Gene · 9582
Papers1,875
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,875
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multifaceted functions of Drp1 in hypoxia/ischemia-induced mitochondrial quality imbalance: from regulatory mechanism to targeted therapeutic strategy. | Mil Med Res | 2023 | 37833768 | PubTator, text mining | PubMed |
| Structure-guided inhibition of the cancer DNA-mutating enzyme APOBEC3A. | Nat Commun | 2023 | 37821454 | PubTator, text mining | PubMed |
| Immune Cell Abundance and T-cell Receptor Landscapes Suggest New Patient Stratification Strategies in Head and Neck Squamous Cell Carcinoma. | Cancer Res Commun | 2023 | 37819239 | PubTator, text mining | PubMed |
| The role of APOBEC3C in modulating the tumor microenvironment and stemness properties of glioma: evidence from pancancer analysis. | Front Immunol | 2023 | 37809064 | PubTator, text mining | PubMed |
| Human APOBEC3B promotes tumor development in vivo including signature mutations and metastases. | Cell Rep Med | 2023 | 37797615 | PubTator, text mining | PubMed |
| Severe Asthma and Biological Therapies: Now and the Future. | J Clin Med | 2023 | 37762787 | PubTator, text mining | PubMed |
| Evaluating the Utility of ctDNA in Detecting Residual Cancer and Predicting Recurrence in Patients with Serous Ovarian Cancer. | Int J Mol Sci | 2023 | 37762691 | PubTator, text mining | PubMed |
| Mechanism of HBx carcinogenesis interaction with non-coding RNA in hepatocellular carcinoma. | Front Oncol | 2023 | 37746253 | PubTator, text mining | PubMed |
| APOBEC3B regulates R-loops and promotes transcription-associated mutagenesis in cancer. | Nat Genet | 2023 | 37735199 | PubTator, text mining | PubMed |
| An updated systemic review and meta-analysis on human papillomavirus in breast carcinogenesis. | Front Oncol | 2023 | 37711194 | PubTator, text mining | PubMed |
| Identification of microRNA editing sites in clear cell renal cell carcinoma. | Sci Rep | 2023 | 37704698 | PubTator, text mining | PubMed |
| Proteogenomics of different urothelial bladder cancer stages reveals distinct molecular features for papillary cancer and carcinoma in situ. | Nat Commun | 2023 | 37704624 | PubTator, text mining | PubMed |
| Advantages of the Combinatorial Molecular Targeted Therapy of Head and Neck Cancer-A Step before Anakoinosis-Based Personalized Treatment. | Cancers (Basel) | 2023 | 37686523 | PubTator, text mining | PubMed |
| Exploration of Key Immune-Related Transcriptomes Associated with Doxorubicin-Induced Cardiotoxicity in Patients with Breast Cancer. | Cardiovasc Toxicol | 2023 | 37684436 | PubTator, text mining | PubMed |
| APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels. | CRISPR J | 2023 | 37672599 | PubTator, text mining | PubMed |
| IFN-γ: A Crucial Player in the Fight Against HBV Infection? | Immune Netw | 2023 | 37670813 | PubTator, text mining | PubMed |
| Clinical, morphologic and molecular heterogeneity of HPV-associated oropharyngeal cancer. | Oncogene | 2023 | 37666939 | PubTator, text mining | PubMed |
| Mechanisms of tumor-associated macrophages affecting the progression of hepatocellular carcinoma. | Front Pharmacol | 2023 | 37663266 | PubTator, text mining | PubMed |
| Epstein-Barr Viral Infection and the Risk for Breast Cancer: A Systematic Review. | Int J Hematol Oncol Stem Cell Res | 2023 | 37637768 | PubTator, text mining | PubMed |
| Understanding DNA Damage Response and DNA Repair in Multiple Myeloma. | Cancers (Basel) | 2023 | 37627183 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9582/papers?page=9